Evaluation of Benztropine for Cocaine Craving - 2

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Cocaine-Related Disorders

Treatments

Drug: Benztropine

Study type

Interventional

Funder types

Other U.S. Federal agency
NIH

Identifiers

NCT00000333
Y01-3-0009-2
NIDA-3-0009-2

Details and patient eligibility

About

The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.

Sex

All

Ages

22 to 48 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems